At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 49 enrolled
Drug / intervention
Restylane Lidocaine +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Evaluator-blind Comparative Study to Evaluate Performance and Safety of Restylane Lidocaine and No-treatment Control for Treatment of Depressed Facial Acne Scars
In Brief
A Phase 4 clinical trial evaluating Restylane Lidocaine and No-treatment control for Healthy Volunteers. Completed, enrolled 49 participants across 2 sites.
Detailed Summary
The purpose of this study is to evaluate performance and safety of Restylane Lidocaine for treatment of depressed facial acne scars
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesGermany
Collaborators--
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
Enrollment StartApr 2017
First PostedApr 2017
Primary CompletionFeb 2018
Study CompletionNov 2018
TodayJul 2026
First PostedApr 25, 2017
Enrollment StartApr 20, 2017
Primary CompletionFeb 15, 2018
Study CompletionNov 8, 2018
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.2 years ago
Interventions
Restylane Lidocainedevice
Hyaluronic acid based filler
No-treatment controlother
No-treatment control